DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study. - Wikidata - wikimedia - TriplyDB

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

http://www.wikidata.org/entity/Q37158951

about

Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.Exon skipping: a first in class strategy for Duchenne muscular dystrophy.Translational development of splice-modifying antisense oligomers.Seeking a better landscape for therapy development in neuromuscular disorders.Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic.Shorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMD Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DNHS)Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy

P2860

Q37396900-704A48C6-9690-4DB6-8BD2-A919FD04B0B2 Q38784820-47DF9354-1903-4C10-8BF1-D63A30AFC347 Q38996657-C7A475A9-053F-429B-89CA-B75973471610 Q42688781-6F6CECEF-1ED9-4457-A180-29DBD554644C Q47704855-3335DCE6-D771-4398-812C-5AF62BC25DCC Q50146624-9700DBB8-126B-43E9-84AD-DA045B67ACAC Q58577259-F50727F1-5CF9-4A34-B674-794304439A30 Q59138454-238377C4-DF61-41E9-B87F-5EDC4F06C063 Q61811913-e88b1bf5-44a4-4997-360c-a383d837759a

P2860

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

http://www.wikidata.org/entity/Q37158951

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

@en

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

@nl

type

label

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

@en

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

@nl

prefLabel

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

@en

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

@nl

P1433

Q37158951-ABEFFF03-E4AA-496E-A7D0-CD650E094D46

P1476

Q37158951-C9FB83F3-6AB0-4055-8EA3-4539405AB1DE

P2093

Q37158951-3CA97102-96FF-498C-980F-0E185D792514

Q37158951-AAAF03CE-B3EC-4660-9DE9-54E4A1184887

Q37158951-D618F353-0CFD-40AB-9A96-ABB291A4B9E8

Q37158951-D7D8C5AD-03E4-4E31-A565-AC8845284EF0

Q37158951-F3543D57-FB40-43D2-85C7-9B4A8D5CA5BB

P2860

Q37158951-05ED2037-FFC3-405B-81DF-3CEBD53A6AB3

Q37158951-2543895E-8079-426F-8D68-23FC2777185F

Q37158951-3012055B-27E7-4F47-B569-4FF51B0E51AD

Q37158951-397D93C9-4E37-40CF-AEEB-A44C30A0F5D9

Q37158951-3F04FADD-B5CB-40A4-ABAC-189389632265

Q37158951-4747821A-19C9-4B7E-AFCC-62C9CDE7EA19

Q37158951-4F61BB52-5C64-4A8F-B658-C11E56932132

Q37158951-532ED930-9511-441B-A436-FCEC31592338

Q37158951-572DCD83-2AD8-4376-801D-3B49C2556D9A

Q37158951-5A88237B-6548-4539-B23A-6B1DB7FBE6AF

P304

Q37158951-6391DACE-E534-444C-A8B4-333CFD5F0B79

P31

Q37158951-EF1A7987-5F5C-4508-9573-59F689699204

P356

Q37158951-DE966684-AF3C-48E9-A35A-0E30772BE774

P407

Q37158951-6D12F658-79C6-4485-95B7-6844FB1C5904

P433

Q37158951-3840B3BB-AC7D-43C9-879D-566791528B70

P478

Q37158951-BC309439-9BF3-469F-8410-3B19ABD59142

P50

Q37158951-76592EBE-5509-492E-B4F5-C22E63B8DFEB

Q37158951-B6DBC3EB-635A-454C-89C1-CA3178C1ED94

P577

Q37158951-1546695F-7FD7-4AF2-9448-F85E349E6CE4

P698

Q37158951-9934E5AD-4845-4813-8B96-E38704A32CD8

P932

Q37158951-897E8F08-46BD-4F3B-95C4-E41381F0B868

P356

WNL.0000000000002891

P1433

P1476

DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

@en

P2093

CINRG investigators

http://www.w3.org/2001/XMLSchema#string

Eric P Hoffman

http://www.w3.org/2001/XMLSchema#string

Heather Gordish-Dressman

http://www.w3.org/2001/XMLSchema#string

Lauren P Morgenroth

http://www.w3.org/2001/XMLSchema#string

Sebahattin Cirak

http://www.w3.org/2001/XMLSchema#string

P2860

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.

Deletions in the 5' region of dystrophin and resulting phenotypes.

What Can We Learn From Clinical Trials of Exon Skipping for DMD?

The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing an

LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.

P304

401-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000002891

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Craig M. McDonald

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27343068

http://www.w3.org/2001/XMLSchema#string

P932

4977110

http://www.w3.org/2001/XMLSchema#string